Search Results for ''

published presentations and documents on DocSlides.

Phase 2 of new ARVs
Phase 2 of new ARVs
by mitsue-stanley
Fostemsavir. , . prodrug. of . temsavir. . (. a...
Developing and Using Key Messages
Developing and Using Key Messages
by phoebe-click
. Overview. This session will cover how to: . D...
Cocaine Abstinence and Reduced Use are Associated with Lowe
Cocaine Abstinence and Reduced Use are Associated with Lowe
by tawny-fly
Africa. n. . Americans: A Preliminary Study . Sh...
AIDSACTIONBALTIMORE TOWN HALL COVID-19VACCINES
AIDSACTIONBALTIMORE TOWN HALL COVID-19VACCINES
by cillian
COVID-19VACCINES. AIDS ACTION BALTIMORE. Lynda Dee...
Julie  Zuñiga , PhD, RN
Julie Zuñiga , PhD, RN
by manuel
Self Management of Diabetes for Persons with HIV. ...
Renal function in the PROUD study, a pragmatic open label randomised trial of
Renal function in the PROUD study, a pragmatic open label randomised trial of
by grady822
Truvada. as pre-exposure prophylaxis. Iain Reeves...
Cabotegravir plus  Rilpivirine
Cabotegravir plus Rilpivirine
by jaxson809
Extended Release Injectable Suspension. Last Updat...
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
Stephanie Cox Gilead Sciences
Stephanie Cox Gilead Sciences
by emery
Foster City, CA. ULTRASENSITIVE HIV-1 DRUG RESISTA...
Genotype-directed dosing for
Genotype-directed dosing for
by bency
Efavirenz. . T. G MBENGERANWA. Harare Family Care...
Patricia A. Cioe, PhD 1 , Alexander W. Sokolovsky, PhD
Patricia A. Cioe, PhD 1 , Alexander W. Sokolovsky, PhD
by rodriguez
1. , Judson A. Brewer, M.D., PhD. 1. , Christopher...
EATG/ i -Base zoom meeting:
EATG/ i -Base zoom meeting:
by callie
19 May 2020. COVID-19 update. :. Summary of studie...
Any PRM at baseline Yes No
Any PRM at baseline Yes No
by lucy
39. 129. 100 . (91, 100). 98 . (95, 100). NRTI PRM...
Lenacapavir  with  bNAbs
Lenacapavir with bNAbs
by skylar
. Teropavimab. (GS-5423) and . Zinlirvimab. (GS-...
GS-US-380-1878 GS-US-380-1844
GS-US-380-1878 GS-US-380-1844
by phoebe
GS-US-380-1961. . Switch to BIC/FTC/TAF. Design...
Clemensia   Nakabiito ,
Clemensia Nakabiito ,
by anastasia
MBChB, . Mmed. Phionah Kibalama Ssemambo, MPH, MBC...
IM Cabotegravir and IM  Rilpivirine
IM Cabotegravir and IM Rilpivirine
by brooke
Every 2 Months for HIV Maintenance. . ATLAS-2M. I...
Immune surveillance and viral shedding
Immune surveillance and viral shedding
by garcia
81 4 Subclinical reactivation of VZV has been less...
International Journal of Medicine and Medical Sciences Vol 33 pp
International Journal of Medicine and Medical Sciences Vol 33 pp
by williams
84 Int. J. Med. Med. Sci. Figure 1. Pr...
ERIC at the
ERIC at the
by candy
UNC CH Department of Epidemiology Medical Center ...
Article published online 20210809
Article published online 20210809
by danya
1 Avicenna Journal of Medicine / Jan-Mar 2014 / Vo...
Generic  tenofovir   disoproxil
Generic tenofovir disoproxil
by SunkissedBabe
fumarate and . emtricitabine. tablets obtained fr...
Innovation and Access to Medicines: A Case Study for HIV/AIDS and Hepatitis
Innovation and Access to Medicines: A Case Study for HIV/AIDS and Hepatitis
by SugarAndSpice
C. Dr . Manica. . Balasegaram. , WIPO Seminar, 20...
Safety and acceptability trial of the dapivirine vaginal ring in U.S. adolescents
Safety and acceptability trial of the dapivirine vaginal ring in U.S. adolescents
by ximena
K. Bunge. , L. Levy, D. Szydlo, J. Zhang, A. Gaur,...
Tenofovir   Alafenamide  (TAF)
Tenofovir Alafenamide (TAF)
by nicole
in a Single-Tablet Regimen . in Initial HIV-1 Ther...
MTN-037 Safety Overview of Topics
MTN-037 Safety Overview of Topics
by gelbero
Physical Examination: . Timing and Documentation. ...
Correctly modeling CD4 cell count in Cox regression analysis of HIV-positive patients
Correctly modeling CD4 cell count in Cox regression analysis of HIV-positive patients
by gagnon
Allison Dunning, M.S.. Research Biostatistician. W...
Fostemsavir in Treatment-Experienced Patients
Fostemsavir in Treatment-Experienced Patients
by joanne
BRIGHTE Study (Week 48 Data). Fostemsavir (FTR) fo...
Establishing a surveillance system:
Establishing a surveillance system:
by violet
the Malawi Experience. Dr.. George bello. HIV Sur...
NATURE BIOTECHNOLOGY   VOLUME 30   NUMBER 4   APRIL 2012
NATURE BIOTECHNOLOGY VOLUME 30 NUMBER 4 APRIL 2012
by belinda
333converted into homozygous parental breeding lin...
WORKING DRAFTDO NOT CITE WITHOUT PERMISSION FROM THE AUTHORSWord Count
WORKING DRAFTDO NOT CITE WITHOUT PERMISSION FROM THE AUTHORSWord Count
by tracy
Abstract Background To reduce injection drug use (...
SASA Mobilizing Communities to End Violence against Women and HIVAID
SASA Mobilizing Communities to End Violence against Women and HIVAID
by jordyn
(Uganda) SASA! is a programme developed by Raisi...
EVALUATION REPORT:
EVALUATION REPORT:
by erica
IMPLEMENTATION SCIENCE RESEARCH E valuating the c...
Phase 2 of new ARVs Fostemsavir
Phase 2 of new ARVs Fostemsavir
by sportyinds
, . prodrug. of . temsavir. . (. attachment inhi...
Kevin Rebe Anova  Health Institute
Kevin Rebe Anova Health Institute
by iainnoli
Cape Town, South Africa. Hyperosmolar Lubricant St...